Scholarship INC.

MEDICINE MAN TECHNOLOGIES, INC.  Management's Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q) |  MarketScreener

Organicell Regenerative Medicine: Responds to Recent Promotional Activities as Demand from OTC Markets – Form 8-K | MarketScreener

Organicell Regenerative Medicine, Inc. responds to recent promotional activities as requested by OTC markets Davie, Florida – November 21, 2022 – Organicell Regenerative Medicine, Inc. (OTCQB: OCEL) (“Organicell” or the “Company“) was requested by OTC Markets Group, Inc. (“OTC markets“) to release this statement on promotional activity regarding its common stock. On November 17, 2022, …

Organicell Regenerative Medicine: Responds to Recent Promotional Activities as Demand from OTC Markets – Form 8-K | MarketScreener Read More »

MEDICINE MAN TECHNOLOGIES, INC.  Management's Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q) |  MarketScreener

MEDICINE MAN TECHNOLOGIES, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q) | MarketScreener

The following discussion should be read in conjunction with our unaudited consolidated financial statements and notes thereto included herein and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC. In addition to our historical unaudited condensed consolidated financial …

MEDICINE MAN TECHNOLOGIES, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q) | MarketScreener Read More »